Conversely, unresponsive patients show minimal changes in outcomes, suggesting that factors beyond L- carnitine adequacy may contribute to their unresponsiveness
Allergen Information: The product does not contain sugar, wheat, gluten, soy, or dairy
Coverage is generally limited to patients with type 2 diabetes who meet strict criteria
Some will say the FDA has explicitly ruled affordability does not constitute a clinical need
Summary: GLP-1 medications slow gut motility and gastric emptying, leading to harder stools and constipation, which can be managed through increased dietary fibre, adequate hydration, regular physical activity, and appropriate laxative use when necessary
Injection Technique General subcutaneous technique references are included for preparation and measurement context [15] [16] [17]